155 related articles for article (PubMed ID: 15301553)
1. Activation and substrate specificity of caspase-14.
Mikolajczyk J; Scott FL; Krajewski S; Sutherlin DP; Salvesen GS
Biochemistry; 2004 Aug; 43(32):10560-9. PubMed ID: 15301553
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of active caspase-14 from human epidermis and development of the cleavage site-directed antibody.
Hibino T; Fujita E; Tsuji Y; Nakanishi J; Iwaki H; Katagiri C; Momoi T
J Cell Biochem; 2010 Feb; 109(3):487-97. PubMed ID: 19960512
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of constitutively active human caspase-14.
Park K; Kuechle MK; Choe Y; Craik CS; Lawrence OT; Presland RB
Biochem Biophys Res Commun; 2006 Sep; 347(4):941-8. PubMed ID: 16854378
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing.
Vántus T; Vertommen D; Saelens X; Rykx A; De Kimpe L; Vancauwenbergh S; Mikhalap S; Waelkens E; Kéri G; Seufferlein T; Vandenabeele P; Rider MH; Vandenheede JR; Van Lint J
Cell Signal; 2004 Jun; 16(6):703-9. PubMed ID: 15093611
[TBL] [Abstract][Full Text] [Related]
5. The proteolytic procaspase activation network: an in vitro analysis.
Van de Craen M; Declercq W; Van den brande I; Fiers W; Vandenabeele P
Cell Death Differ; 1999 Nov; 6(11):1117-24. PubMed ID: 10578181
[TBL] [Abstract][Full Text] [Related]
6. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
[TBL] [Abstract][Full Text] [Related]
7. Structure-based thermodynamic analysis of caspases reveals key residues for dimerization and activity.
Piana S; Sulpizi M; Rothlisberger U
Biochemistry; 2003 Jul; 42(29):8720-8. PubMed ID: 12873132
[TBL] [Abstract][Full Text] [Related]
8. [W206R]-procaspase 3: an inactivatable substrate for caspase 8.
Rank KB; Mildner AM; Leone JW; Koeplinger KA; Chou KC; Tomasselli AG; Heinrikson RL; Sharma SK
Protein Expr Purif; 2001 Jul; 22(2):258-66. PubMed ID: 11437602
[TBL] [Abstract][Full Text] [Related]
9. Engineered hybrid dimers: tracking the activation pathway of caspase-7.
Denault JB; Békés M; Scott FL; Sexton KM; Bogyo M; Salvesen GS
Mol Cell; 2006 Aug; 23(4):523-33. PubMed ID: 16916640
[TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
Keller N; Mares J; Zerbe O; Grütter MG
Structure; 2009 Mar; 17(3):438-48. PubMed ID: 19278658
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new caspase homologue: caspase-14.
Van de Craen M; Van Loo G; Pype S; Van Criekinge W; Van den brande I; Molemans F; Fiers W; Declercq W; Vandenabeele P
Cell Death Differ; 1998 Oct; 5(10):838-46. PubMed ID: 10203698
[TBL] [Abstract][Full Text] [Related]
12. Studies of the molecular mechanism of caspase-8 activation by solution NMR.
Keller N; Grütter MG; Zerbe O
Cell Death Differ; 2010 Apr; 17(4):710-8. PubMed ID: 19851329
[TBL] [Abstract][Full Text] [Related]
13. Caspase structure, proteolytic substrates, and function during apoptotic cell death.
Nicholson DW
Cell Death Differ; 1999 Nov; 6(11):1028-42. PubMed ID: 10578171
[TBL] [Abstract][Full Text] [Related]
14. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing.
Lippens S; Kockx M; Knaapen M; Mortier L; Polakowska R; Verheyen A; Garmyn M; Zwijsen A; Formstecher P; Huylebroeck D; Vandenabeele P; Declercq W
Cell Death Differ; 2000 Dec; 7(12):1218-24. PubMed ID: 11175259
[TBL] [Abstract][Full Text] [Related]
15. Expression, preparation, and high-throughput screening of caspase-8: discovery of redox-based and steroid diacid inhibition.
Smith GK; Barrett DG; Blackburn K; Cory M; Dallas WS; Davis R; Hassler D; McConnell R; Moyer M; Weaver K
Arch Biochem Biophys; 2002 Mar; 399(2):195-205. PubMed ID: 11888206
[TBL] [Abstract][Full Text] [Related]
16. Human and murine granzyme B exhibit divergent substrate preferences.
Cullen SP; Adrain C; Lüthi AU; Duriez PJ; Martin SJ
J Cell Biol; 2007 Feb; 176(4):435-44. PubMed ID: 17283187
[TBL] [Abstract][Full Text] [Related]
17. Caspase activation: revisiting the induced proximity model.
Shi Y
Cell; 2004 Jun; 117(7):855-8. PubMed ID: 15210107
[TBL] [Abstract][Full Text] [Related]
18. Caspase-14 but not caspase-3 is processed during the development of fetal mouse epidermis.
Fischer H; Rossiter H; Ghannadan M; Jaeger K; Barresi C; Declercq W; Tschachler E; Eckhart L
Differentiation; 2005 Oct; 73(8):406-13. PubMed ID: 16316411
[TBL] [Abstract][Full Text] [Related]
19. Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytes.
Paulsen M; Ussat S; Jakob M; Scherer G; Lepenies I; Schütze S; Kabelitz D; Adam-Klages S
Eur J Immunol; 2008 Jul; 38(7):1979-87. PubMed ID: 18521960
[TBL] [Abstract][Full Text] [Related]
20. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
